Differences Between TCT and HPV Testing in Cervical Cancer Screening

Mar 16, 2022 Source: Cainiu Health
Dr. Xu Yongqian
Introduction
Differences Between TCT and HPV Testing in Cervical Cancer Screening: Both HPV testing and TCT (ThinPrep Cytologic Test) are methods used for cervical cancer screening. TCT is a more advanced cervical cytology technique that collects cells from the cervical canal to detect cervical cancer or precancerous changes. HPV testing involves collecting mucus and secretions from the lesion site to detect high-risk human papillomavirus (HPV) infection, which is strongly associated with cervical cancer development. If HPV testing yields abnormal results, colposcopy is typically recommended for further evaluation.

The incidence of cervical cancer among women in China is increasing year by year. For patients diagnosed with cervical cancer, early detection and timely treatment can significantly improve quality of life and extend survival. Among cervical cancer screening methods, the ThinPrep Cytology Test (TCT) and Human Papillomavirus (HPV) testing are the most commonly used. So, what are the key differences between TCT and HPV testing for cervical cancer screening? Let’s explore them below.

Differences Between TCT and HPV Testing in Cervical Cancer Screening

1. Different Focus of Examination

HPV testing involves collecting mucus and secretions from the lesion site to screen for infection with human papillomavirus in cervical cells; its primary focus is viral detection. In contrast, TCT examines cervical cells for abnormal changes induced by HPV infection, with its main emphasis on cellular and tissue morphology.

2. Different Target Populations

TCT is a relatively advanced cervical cancer detection technique that collects cells from the cervical canal to determine whether a patient has cervical cancer. HPV testing is suitable not only for women at risk for or diagnosed with cervical cancer but also for those presenting symptoms such as abnormal vaginal discharge, recurrent genital tract infections, cervical ectropion (formerly termed “cervical erosion”), or postcoital bleeding. TCT is primarily indicated for women with known or suspected cervical disease—including cervical cancer, cervicitis, or malignant lesions within the cervical canal. In clinical practice, most women undergoing cervical cancer screening receive both TCT and HPV testing concurrently.

The above outlines the key distinctions between TCT and HPV testing in cervical cancer screening. Cervical cancer is now one of the more common malignancies among women, yet it boasts an exceptionally high cure rate when detected and treated early. During routine gynecological examinations at hospitals, physicians typically recommend regular cervical cytology screening—i.e., TCT—to facilitate early prevention and detection of cervical cancer. We hope this information proves helpful to you.